Kamal Hezam

29.6k total citations
21 papers, 528 citations indexed

About

Kamal Hezam is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Kamal Hezam has authored 21 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Kamal Hezam's work include Mesenchymal stem cell research (5 papers), Extracellular vesicles in disease (3 papers) and Immune Cell Function and Interaction (3 papers). Kamal Hezam is often cited by papers focused on Mesenchymal stem cell research (5 papers), Extracellular vesicles in disease (3 papers) and Immune Cell Function and Interaction (3 papers). Kamal Hezam collaborates with scholars based in China, Yemen and Australia. Kamal Hezam's co-authors include Awais Ullah Ihsan, Ding Qi-long, Hui Lei, Abdoh Taleb, Na Lin, Khalil Ali Ahmad, Zongjin Li, Yue Liu, Zhongchao Han and Zhibo Han and has published in prestigious journals such as Experimental Cell Research, Journal of Applied Polymer Science and Biomedicine & Pharmacotherapy.

In The Last Decade

Kamal Hezam

20 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamal Hezam China 10 207 87 77 69 58 21 528
Jasmin Shafarin United Arab Emirates 16 305 1.5× 69 0.8× 91 1.2× 60 0.9× 26 0.4× 37 653
Mo Yang China 14 281 1.4× 83 1.0× 65 0.8× 54 0.8× 25 0.4× 40 711
Qiuxia Yu China 17 304 1.5× 85 1.0× 49 0.6× 64 0.9× 82 1.4× 93 795
Daye Cheng China 16 206 1.0× 111 1.3× 53 0.7× 96 1.4× 37 0.6× 29 716
Kentaro Sugiyama Japan 15 273 1.3× 113 1.3× 52 0.7× 93 1.3× 70 1.2× 70 715
Marwa O. El-Derany Egypt 15 215 1.0× 42 0.5× 83 1.1× 46 0.7× 24 0.4× 25 597
Pushplata Sankhwar India 16 268 1.3× 57 0.7× 81 1.1× 87 1.3× 35 0.6× 46 783
Masum M. Mia Singapore 17 401 1.9× 64 0.7× 85 1.1× 92 1.3× 70 1.2× 25 1.1k
Qing Wen China 10 320 1.5× 116 1.3× 68 0.9× 108 1.6× 23 0.4× 38 770
Ganna Tolstanova Ukraine 15 280 1.4× 69 0.8× 64 0.8× 78 1.1× 38 0.7× 72 660

Countries citing papers authored by Kamal Hezam

Since Specialization
Citations

This map shows the geographic impact of Kamal Hezam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamal Hezam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamal Hezam more than expected).

Fields of papers citing papers by Kamal Hezam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamal Hezam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamal Hezam. The network helps show where Kamal Hezam may publish in the future.

Co-authorship network of co-authors of Kamal Hezam

This figure shows the co-authorship network connecting the top 25 collaborators of Kamal Hezam. A scholar is included among the top collaborators of Kamal Hezam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamal Hezam. Kamal Hezam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hezam, Kamal, et al.. (2024). In vivo tracking of mesenchymal stem cell dynamics and therapeutics in LPS-induced acute lung injury models. Experimental Cell Research. 437(2). 114013–114013. 3 indexed citations
2.
You, Wenpeng, Leandro García, Kamal Hezam, & Hui‐Chen Chang. (2024). Limited role of biological aging in unhealthy aging: A cross-sectional analysis of global life expectancy and disability data. Archives of Gerontology and Geriatrics. 129. 105691–105691.
3.
Hezam, Kamal, et al.. (2024). Therapeutic trends of priming mesenchymal stem cells: A bibliometric analysis. Biochemistry and Biophysics Reports. 38. 101708–101708. 7 indexed citations
4.
Hezam, Kamal, Chen Wang, Manqian Zhou, et al.. (2023). Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage immunomodulation. Stem Cell Research & Therapy. 14(1). 48–48. 34 indexed citations
5.
Mubarik, Sumaira, Fang Wang, Lisha Luo, Kamal Hezam, & Chuanhua Yu. (2023). Evaluation of Lee–Carter model to breast cancer mortality prediction in China and Pakistan. Frontiers in Oncology. 13. 1101249–1101249. 6 indexed citations
6.
Zhu, Mengfan, Xunhao Wang, Yan Zhou, et al.. (2023). Breast tumor‐targeted drug delivery via polymer nanocarriers: Endogenous and exogenous strategies. Journal of Applied Polymer Science. 140(31). 9 indexed citations
7.
Al‐Azab, Mahmoud, Elina Idiiatullina, Mohammed Safi, & Kamal Hezam. (2023). Enhancers of mesenchymal stem cell stemness and therapeutic potency. Biomedicine & Pharmacotherapy. 162. 114356–114356. 16 indexed citations
8.
Jin, Yingzhao, Ester Cerin, Anthony Barnett, et al.. (2023). The temporal trend of disease burden attributable to metabolic risk factors in China, 1990–2019: An analysis of the Global Burden of Disease study. Frontiers in Nutrition. 9. 1035439–1035439. 5 indexed citations
9.
Hezam, Kamal, et al.. (2022). Prevalence of Intestinal Parasites among Immunocompromised Patients, Children, and Adults in Sana’a, Yemen. Journal of Tropical Medicine. 2022. 1–12. 9 indexed citations
10.
Xu, Yao, et al.. (2021). The efficacy and safety of Nivolumab combined with Ipilimumab in the immunotherapy of cancer: a meta-analysis. Immunopharmacology and Immunotoxicology. 43(3). 386–394. 7 indexed citations
11.
Li, Zongjin, et al.. (2021). Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomesin Pneumonia. Current Pharmaceutical Biotechnology. 23(9). 1153–1167. 8 indexed citations
12.
Liu, Yue, Jian Cui, Hongfen Wang, et al.. (2020). Enhanced therapeutic effects of MSC-derived extracellular vesicles with an injectable collagen matrix for experimental acute kidney injury treatment. Stem Cell Research & Therapy. 11(1). 161–161. 81 indexed citations
13.
Hezam, Kamal, et al.. (2020). Diacerein: Recent insight into pharmacological activities and molecular pathways. Biomedicine & Pharmacotherapy. 131. 110594–110594. 78 indexed citations
14.
Hezam, Kamal, et al.. (2020). Recent insights of the role and signalling pathways of interleukin-34 in liver diseases. International Immunopharmacology. 89(Pt B). 107023–107023. 8 indexed citations
15.
Al‐Gheethi, Adel, Efaq Ali Noman, Qais Ali Al‐Maqtari, et al.. (2020). Novel Coronavirus (2019-nCoV) Outbreak; A Systematic Review for Published Papers. SSRN Electronic Journal. 8 indexed citations
16.
Han, Yue, Fumou Sun, Xinrong Zhang, et al.. (2019). CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy. Journal of Cancer Research and Clinical Oncology. 145(5). 1179–1190. 37 indexed citations
17.
Taleb, Abdoh, Khalil Ali Ahmad, Awais Ullah Ihsan, et al.. (2018). Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomedicine & Pharmacotherapy. 102. 689–698. 166 indexed citations
18.
Li, Huilan, Qianqian Qiu, Chunxia Liu, et al.. (2018). Design, synthesis and evaluation of a novel series of inhibitors reversing P‐glycoprotein‐mediated multidrug resistance. Chemical Biology & Drug Design. 92(3). 1708–1716. 15 indexed citations
19.
Hezam, Kamal, et al.. (2017). Artemin promotes oncogenicity, metastasis and drug resistance in cancer cells. Reviews in the Neurosciences. 29(1). 93–98. 11 indexed citations
20.
Hezam, Kamal, et al.. (2016). Prevalence of Parasitic Helminthes among Slaughtered Animals in Slaughterhouses in Taiz, Yemen. International Journal of Current Microbiology and Applied Sciences. 5(8). 80–88. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasmin Shafarin Breakdown of academic impact, for papers by Mo Yang Breakdown of academic impact, for papers by Qiuxia Yu Breakdown of academic impact, for papers by Daye Cheng Breakdown of academic impact, for papers by Kentaro Sugiyama Breakdown of academic impact, for papers by Marwa O. El-Derany Breakdown of academic impact, for papers by Pushplata Sankhwar Breakdown of academic impact, for papers by Masum M. Mia Breakdown of academic impact, for papers by Qing Wen Breakdown of academic impact, for papers by Ganna Tolstanova
Rankless by CCL
2026